Limiting damage during infection: lessons from infection tolerance for novel therapeutics.
about
Beyond killing: Can we find new ways to manage infection?Nrf2 as a master regulator of tissue damage control and disease tolerance to infectionMast cells and influenza a virus: association with allergic responses and beyond.Disentangling human tolerance and resistance against HIV.Role of disease-associated tolerance in infectious superspreadersCo-infection alters population dynamics of infectious disease.How to live with the enemy: understanding tolerance to parasites.Integrated whole-genome screening for Pseudomonas aeruginosa virulence genes using multiple disease models reveals that pathogenicity is host specific.How to Use a Chemotherapeutic Agent When Resistance to It Threatens the Patient.The adaptive evolution of virulence: a review of theoretical predictions and empirical testsManipulating virulence factor availability can have complex consequences for infections.Defining Resistance and Tolerance to Cancer.Microbe-mediated host defence drives the evolution of reduced pathogen virulence.Nonlinear disease tolerance curves reveal distinct components of host responses to viral infection.Quorum sensing protects bacterial co-operation from exploitation by cheats.A small-molecule antivirulence agent for treating Clostridium difficile infection.Gut physiology mediates a trade-off between adaptation to malnutrition and susceptibility to food-borne pathogens.Epidemiological consequences of immune sensitisation by pre-exposure to vector saliva.Health trajectories reveal the dynamic contributions of host genetic resistance and tolerance to infection outcome.Adaptation to public goods cheats in Pseudomonas aeruginosa.Assessing the public health impact of tolerance-based therapies with mathematical models.Predictive modelling of a novel anti-adhesion therapy to combat bacterial colonisation of burn wounds.Tolerance to Plant Pathogens: Theory and Experimental Evidence.The Diversity of Mammalian Hemoproteins and Microbial Heme Scavengers Is Shaped by an Arms Race for Iron Piracy
P2860
Q26750724-6DD20A5B-B25E-485A-AA06-EBE0EA14062DQ26778359-BCE4FB6A-34B0-4353-B184-0071DD275A32Q30375297-3B6D1750-8BF9-48DA-8B88-6F9F4166CA08Q34195511-F5202B7A-9C18-4B18-83DA-BE148B0F1E5BQ34480636-D670CB8C-4E08-4439-BA91-ADC7E86711B3Q35160585-B82C96D3-402E-4ECE-A780-5C4A954F1717Q35391820-23662223-07D2-4247-A742-D0926B2CB9FBQ35595533-D9F5167F-2DE6-42B8-ACC2-AF96A0A2776CQ36275612-1F26E740-9FF5-4320-8E2E-0FF836FED651Q36919489-1D16561F-CBEB-48B4-816D-F748D851FEBFQ37539878-89467EEE-0580-404E-93FF-5AC1289B153BQ38574485-CE6A210A-55AE-43F1-97C0-ACB0A4599BE5Q39187216-EC767D39-2791-4B91-8515-8296251FABADQ40089874-679D9685-54BC-42E7-A632-7A3C2704A756Q40129838-110D89FA-D7D4-4542-AF5A-FBBBF59B664CQ40984710-D97A7F86-8F85-4621-919C-CE37556C551CQ41065730-10A39FDF-2730-4E90-94EB-AFAC3137B960Q44168829-91BA18DB-1CEB-4575-A056-1C6DF9A66768Q51057325-AB32E7F9-68FF-4386-B51E-B4913E216546Q53140800-109DC490-D0A2-4796-A406-7E0FF1FAE2D9Q54974553-4ECBDE34-819F-4186-A0BE-DAC9E927445CQ55001925-5C9DDC40-F845-4900-9C3B-D6709524ADADQ55024352-7E5CD672-0E41-49E6-914A-791F89690668Q57113244-9DE03C57-CC6A-4CAD-A224-4E1EF3A9BDEE
P2860
Limiting damage during infection: lessons from infection tolerance for novel therapeutics.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Limiting damage during infecti ...... erance for novel therapeutics.
@en
type
label
Limiting damage during infecti ...... erance for novel therapeutics.
@en
prefLabel
Limiting damage during infecti ...... erance for novel therapeutics.
@en
P2860
P50
P1433
P1476
Limiting damage during infection: lessons from infection tolerance for novel therapeutics
@en
P2093
Sam P Brown
P2860
P304
P356
10.1371/JOURNAL.PBIO.1001769
P407
P577
2014-01-21T00:00:00Z